ADMB-3TMS-PRINACA explained

Iupac Name:	N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(3-(trimethylsilyl)propyl)-1H-indazole-3-carboxamide
Width:	200px
Smiles:	C[Si](C)(C)CCCn1nc(C(=O)N[C@H](C(=O)N)C(C)(C)C)c2ccccc12
C:	20
H:	32
N:	4
O:	2
Si:	1
Stdinchi:	1S/C20H32N4O2Si/c1-20(2,3)17(18(21)25)22-19(26)16-14-10-7-8-11-15(14)24(23-16)12-9-13-27(4,5)6/h7-8,10-11,17H,9,12-13H2,1-6H3,(H2,21,25)(H,22,26)/t17-/m1/s1
Stdinchikey:	LJKMOYFTWIBFJI-QGZVFWFLSA-N

ADMB-3TMS-PRINACA (ADB-3TMS-PRINACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist that has been sold as a designer drug, first identified in Germany in March 2023. It is the first psychoactive drug ever reported that contains a silicon atom.^[1]

Legality

ADMB-3TMS-PRINACA is illegal in Germany and Italy.^[2]

See also

• ADB-PINACA
• ADB-FUBINACA
• CUMYL-3TMS-PRINACA
• Silandrone

Notes and References

1. Web site: New psychoactive substances - the current situation in Europe . European Drug Report . European Union Drugs Agency (EUDA) . 2024 .
2. Web site: Notizie dalla FNOMCeO . News from FNOMCeO . Order of Surgeons and Dentists of the province of Brescia . it . Update of the tables containing the indication of narcotic and psychotropic substances. Inclusion in Table I of the specific indication of the substances: 2'-fluoro-2-fluoro-3-methylfentanyl; N-cyclohexyl butylone; ADMB-3TMSPrinaca .